Sensus Healthcare Inc SRTS
$2.91
▲ +0.69%
(+$0.02)
📅 Earnings This Week
Open
$2.93
Prev Close
$2.89
Day Range
$2.81 – $2.98
52W Range
$2.66 – $5.92
Market Cap
$47.90M
Beta
1.14
EPS (TTM)
$-0.47
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-06-03 |
| Shares Out. | 16,460,000 |
| Website | sensushealthcare.com/ ↗ |
| Phone | 13023513367 |
| Employees | 60 |
| Revenue | $3.4M |
| Gross Profit | $991,000 |
| Net Income | -$2.6M |
| Free Cash Flow | -$740,000 |
| Total Assets | $51.5M |
| Total Liabilities | $6.0M |
| Equity | $45.5M |
About Sensus Healthcare Inc
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Sensus Healthcare Inc is a publicly traded company under the ticker symbol SRTS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)